ok- this was op’s call a while ago.
I believe, the most likely case moving forward with a treatment for CLBP is a $30m trial involving about 300 patients for 12 months duration . If investors don’t want to stick around that long...that’s their choice. I’m back( pun intended), but I will have something to say in the near future about management shortcomings...to say that they were fortunate to secure the backing of Surgecenter is a massive understatement..
Love your work OP
Reg
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-44
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.000(0.00%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21914 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 234146 | 1 |
View Market Depth
| Last trade - 09.39am 01/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable